Categories AlphaGraphs, Earnings, Finance, LATEST
JPMorgan beats estimates on Q4 revenues but misses on earnings
JPMorgan Chase & Company (JPM) reported better-than-expected revenues for the fourth quarter of 2018 but missed estimates on earnings. The stock was down 2.4% in premarket hours on Tuesday.
Reported revenues grew 7% year-over-year to $26.1 billion while managed revenues were up 4% to $26.8 billion. Net income increased 67% to a record $7.1 billion while EPS grew 85% to $1.98 from the same period a year ago.
Net interest income grew 9%, driven by higher rates and loan growth. Non-interest revenue dropped 1% to $12.3 billion. Non-interest expense rose 6%, driven mainly by investments in the business, including technology, marketing and real estate.
Also see: JPMorgan Chase Q4 2018 Earnings Transcript
The provision for credit losses increased by $240 million from last year to $1.5 billion in the quarter, driven by higher net reserve builds in the Consumer and Wholesale portfolios. Return on common equity was 12% in the quarter.
Earnings preview: JPMorgan will brave global headwinds in Q4
JPMorgan saw revenue declines across all its segments except for Consumer & Community Banking. In the Consumer & Community Banking segment, revenues benefited from higher net interest income on higher deposit and card margins and balance growth. Revenues in the Asset & Wealth Management segment were negatively impacted by lower market levels.
Banking stocks have faced pressures from a slowing economy, market volatility and the trade war. On Monday, JPMorgan’s rival Citigroup (C) reported fourth quarter results, beating earnings estimates but missing on revenues.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was